US equities |
TSLA $411.33 ▲+2.88% MU $866.75 ▼-2.03% NVDA $207.26 ▲+1.28% AMZN $251.72 ▲+4.73% SPCX $140.69 ▲+4.43% MSFT $523.68 ▲+0.34% INTC $62.78 ▼-4.53% SNDK $1,120.52 ▼-2.64%
FinancialContent

Articles published by Micron Biomedical

News headline image
Micron Biomedical Appoints Anand Subramony, Ph.D., as Executive Vice President, Global Product Development and Combination Product Commercialization
From Micron Biomedical
Via GlobeNewswire
News headline image
Micron Biomedical Awarded Federal Vaccine Contract to Fight Rotavirus Through The Skin, Without Needles
From Micron Biomedical
Via GlobeNewswire
News headline image
Micron Biomedical Honored with Georgia Life Sciences' Prestigious Phoenix Award for Transformative Research
From Micron Biomedical
Via GlobeNewswire
News headline image
Micron Biomedical Secures $4.5 Million Federal Contract to Develop First Dissolvable Microarray Radiation/Nuclear Medical Countermeasure
From Micron Biomedical
Via GlobeNewswire
News headline image
Micron Biomedical Expands Leadership to Mobilize for Pivotal Studies and Commercialization of First Needle-Free Dissolvable Vaccines and Therapeutics
From Micron Biomedical
Via GlobeNewswire
News headline image
Micron Biomedical Celebrates the Grand Opening of Its Commercial-Scale Manufacturing Site in Georgia
From Micron Biomedical
Via GlobeNewswire
News headline image
Micron Biomedical Named to Fast Company’s 2026 List of World’s Most Innovative Companies for Addressing the Most Significant Bottlenecks in How Medicine is Made, Distributed and Administered
From Micron Biomedical
Via GlobeNewswire
News headline image
Micron Biomedical Names Health Education and Empowerment Advocate, Dr. Jayne Morgan, to Board of Advisors
From Micron Biomedical
Via GlobeNewswire
News headline image
Micron Biomedical Extends Series A Financing to 33+ Million to Accelerate Commercialization of Needle-Free Therapeutics and Vaccines
From Micron Biomedical
Via GlobeNewswire
News headline image
UPDATE - Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop mRNA-Based Broad Protecting Flu Vaccine Without Needles
From Micron Biomedical
Via GlobeNewswire
News headline image
Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop mRNA-Based Broad Protecting Flu Vaccine Without Needles
From Micron Biomedical
Via GlobeNewswire
News headline image
CEPI and Micron Biomedical Accelerate Needle-Free Vaccines against Disease X with $3.7 Million Grant to Advance Learnings from COVID-19
From Micron Biomedical
Via GlobeNewswire
News headline image
Micron Biomedical Secures $43 Million in Total Grant Support to Improve Coverage of Measles and Rubella Vaccine and Accelerate World’s First Phase 2 Trial of Needle-Free Drug and Vaccine Technology in Infants
From Micron Biomedical
Via GlobeNewswire